Adam V. Chambers
CIK: 0002068219
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (0 total)
2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Chambers Adam V
Chambers Adam V (SEC CIK 0002068219) files insider reports with the SEC as Director of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) and Director of iCoreConnect Inc. (ICCT).
Signal8 holds 2 ownership filings by Chambers Adam V, all Form 3s, filed between May 13, 2025 and Sep 8, 2025. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Chambers Adam V's filings is in OCOEE, FL.
Other insiders filing for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- HRT FINANCIAL LP, 10% Owner
- Trasolini Ryan, Co-Chief Executive Officer
- Liang Yuying, Chief Financial Officer
- Liriano Angel, Director
- Pathigoda Arachchige Sachin Eranga, Director
- Richards Steven M, Director